Pooled analysis of monocyte distribution width in subjects with SARS-CoV-2 infection
Corresponding Author
Giuseppe Lippi
Section of Clinical Biochemistry, University of Verona, Verona, Italy
Correspondence
Giuseppe Lippi, Section of Clinical Biochemistry, University Hospital of Verona, Piazzale LA Scuro, 37134 Verona, Italy.
Email: [email protected]
Search for more papers by this authorFabian Sanchis-Gomar
Department of Physiology, Faculty of Medicine, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain
Search for more papers by this authorBrandon M. Henry
Cardiac Intensive Care Unit, The Heart Institute, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA
Search for more papers by this authorCorresponding Author
Giuseppe Lippi
Section of Clinical Biochemistry, University of Verona, Verona, Italy
Correspondence
Giuseppe Lippi, Section of Clinical Biochemistry, University Hospital of Verona, Piazzale LA Scuro, 37134 Verona, Italy.
Email: [email protected]
Search for more papers by this authorFabian Sanchis-Gomar
Department of Physiology, Faculty of Medicine, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain
Search for more papers by this authorBrandon M. Henry
Cardiac Intensive Care Unit, The Heart Institute, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA
Search for more papers by this author
Supporting Information
| Filename | Description |
|---|---|
| ijlh13482-sup-0001-AppendixS1.docWord document, 58 KB | Appendix S1 |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
REFERENCES
- 1Iacobucci G Covid-19: Government faces criticism over pound500m plan to pilot mass testing. BMJ. 2020; 370: m3482.
- 2Crouser ED, Parrillo JE, Seymour C, et al. Improved early detection of sepsis in the ED with a novel monocyte distribution width biomarker. Chest. 2017; 152: 518-526.
- 3Crouser ED, Parrillo JE, Seymour CW, et al. Monocyte distribution width: a novel indicator of sepsis-2 and sepsis-3 in high-risk emergency department patients. Crit Care Med. 2019; 47: 1018-1025.
- 4Karimi Shahri M, Niazkar HR, Rad F COVID-19 and hematology findings based on the current evidences: a puzzle with many missing pieces. Int J Lab Hematol. 2020. https://doi.org/10.1111/ijlh.13412
- 5Lin HA, Lin SF, Chang HW, et al. Clinical impact of monocyte distribution width and neutrophil-to-lymphocyte ratio for distinguishing COVID-19 and influenza from other upper respiratory tract infections: a pilot study. PLoS One. 2020; 15:e0241262.
- 6Ognibene A, Lorubbio M, Magliocca P, et al. Elevated monocyte distribution width in COVID-19 patients: the contribution of the novel sepsis indicator. Clin Chim Acta. 2020; 509: 22-24.
- 7Zeng X, Xing H, Wei Y, et al. Monocyte volumetric parameters and lymph index are increased in SARS-CoV-2 infection. Int J Lab Hematol. 2020; 42: e266-e269.
- 8Frater JL, Zini G, d'Onofrio G, Rogers HJ COVID-19 and the clinical hematology laboratory. Int J Lab Hematol. 2020; 42(Suppl 1): 11-18.
- 9Martinez FO, Combes TW, Orsenigo F, Gordon S Monocyte activation in systemic Covid-19 infection: assay and rationale. EBioMedicine. 2020; 59:102964.
- 10Henry BM, Vikse J, Benoit S, Favaloro EJ, Lippi G Hyperinflammation and derangement of renin-angiotensin-aldosterone system in COVID-19: a novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis. Clin Chim Acta. 2020; 507: 167-173.
Citing Literature
